For more than a decade, Oncology has been the largest therapy area by value, and it continues to grow at a robust pace. Total Oncology spend is expected to reach 409B USD by 2028, driven mainly by branded medicines growth but also by new launches.
The IQVIA Global Oncology team will showcase how IQVIA's Global Oncology Intelligence solutions can help overcome the challenges faced in launching Oncology products, ensure successful market entry and sustained growth. This session will provide valuable insights into navigating the complexities of Oncology launches and demonstrate real-world applications of IQVIA data.
3 key takeaways:
Vladimir Bonevski, Associate Product & Strategy Director - Oncology, IQVIA
Nina Schmidt, Global Oncology Sales Director, IQVIA
Alice Cinzia Perego, Offering Development Director, Global Launch Excellence, IQVIA
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Unravel the complexities of cancer treatment with patient-level data-driven solutions.
.svg){kind=icon}
